2 ml pre-filled syringe

INNOVATIVE TREATMENTS BASED ON LINEAR HYALURONIC ACID WITH HIGH VISCOSITY DEGREE FOR JOINTS AFFECTED BY OA

ALLEVYAL® is an injectable product containing a buffer solution of hyaluronic acid sodium salt with an average molecular weight of 1,500 KDalton, with marked viscoelastic properties. Obtained through the biofermentation of Streptococcus Equi, Allevyal® sodium hyaluronate is rigorously purified.

TREATMENT OF AFFECTED JOINTS

The pre-filled and sterilized disposable glass syringes of Allevyal® differ from those of other competitors, whose range of milligrams of hyaluronic acid oscillates between 15-18 mg/ml: the quantity of HA present in our product is as many as 20 mg/ml.

It is available in two formats:
• Allevyal 2ml - containing 40 mg of hyaluronic acid in 2 ml of buffer solution (2%)
• Allevyal 4ml - containing 80 mg of hyaluronic acid in 4 ml of buffer solution (2%)

Allevyal 2ml

EU Classification: Medical Device Class III
Molecular Chain HA: Linear
Origin: Biofermentation (Streptococcus Equi)
HA Concentration: 40mg/2ml (2%)
Molecular Weight: 1500 KDa
Volume (pre-filled syringe): 2ml
Indications: Treatments for all joints such as, for example, knee, hip, shoulder, fingers
Packaging: Airless System (High Safety Profiles)

Dosage: 2 annual therapies with 2-3 injections one every 15 days

At the discretion of the doctor and based on the patient's condition, treatment of multiple joints at the same time is possible. An interval of at least 6 months is required from any further courses of treatment.

RESULTS
Alleviation of symptoms such as pain and swelling
Recovery of joint function
Healing and preventive effect on tissues
Excellent tolerability
Local and non-systemic action